APTAPHARMA INC FDA Approval ANDA 210602

ANDA 210602

APTAPHARMA INC

FDA Drug Application

Application #210602

Application Sponsors

ANDA 210602APTAPHARMA INC

Marketing Status

Over-the-counter001

Application Products

001SUSPENSION;ORAL100MG/5ML0IBUPROFENIBUPROFEN

FDA Submissions

UNKNOWN; ORIG1AP2018-11-23STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

APTAPHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210602
            [companyName] => APTAPHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"100MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/23\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-11-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.